Strategies for Testing Intervention Matching Schemes in Cancer.

Clinical Pharmacology and Therapeutics
Nicholas J SchorkJeffrey Trent

Abstract

Personalized medicine, or the tailoring of health interventions to an individual's nuanced and often unique genetic, biochemical, physiological, behavioral, and/or exposure profile, is seen by many as a biological necessity given the great heterogeneity of pathogenic processes underlying most diseases. However, testing and ultimately proving the benefit of strategies or algorithms connecting the mechanisms of action of specific interventions to patient pathophysiological profiles (referred to here as "intervention matching schemes" (IMS)) is complex for many reasons. We argue that IMS are likely to be pervasive, if not ubiquitous, in future health care, but raise important questions about their broad deployment and the contexts within which their utility can be proven. For example, one could question the need to, the efficiency associated with, and the reliability of, strategies for comparing competing or perhaps complementary IMS. We briefly summarize some of the more salient issues surrounding the vetting of IMS in cancer contexts and argue that IMS are at the foundation of many modern clinical trials and intervention strategies, such as basket, umbrella, and adaptive trials. In addition, IMS are at the heart of proposed "rap...Continue Reading

References

Jul 16, 1987·The New England Journal of Medicine·B Freedman
Dec 8, 1993·JAMA : the Journal of the American Medical Association·E B LarsonJ Oas
Jan 30, 2007·Health Affairs·Lynn M Etheredge
Apr 14, 2010·Journal of General Internal Medicine·Paul A ScuffhamPaul Glasziou
Jun 30, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Amy P AbernethySharon B Murphy
Oct 6, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel D Von HoffRobert Penny
Dec 18, 2010·Nature Reviews. Genetics·Albert-László BarabásiJoseph Loscalzo
Jun 23, 2011·Personalized Medicine·Elizabeth O LillieNicholas J Schork
Nov 11, 2011·Nature Reviews. Cancer·Xiangwei Wu, Scott M Lippman
May 16, 2012·Cancer Discovery·Edward S KimWaun K Hong
May 1, 2013·Nature Reviews. Drug Discovery·Richard Simon, Sameek Roychowdhury
Apr 8, 2014·Cancer·Justin StebbingDavid Sidransky
Jun 11, 2014·Annals of Medicine·Pasquale F InnominatoFrancis A Lévi
Nov 18, 2014·Annual Review of Statistics and Its Application·Bibhas Chakraborty, Susan A Murphy
Jan 13, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Thomas J GallowayAntonio Jimeno
Jan 18, 2015·Heart·Robert M StoekenbroekUNKNOWN Incremental Decrease in End Points Through Aggressive Lipid Lowering Study Group
Mar 7, 2015·Science·Dirk Haussecker, Mark A Kay
Apr 23, 2015·Nature·Sebastian KreiterUgur Sahin
Apr 24, 2015·Science Translational Medicine·Oliver JonasRobert Langer
Apr 25, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J RodonR Kurzrock
May 1, 2015·Nature·Nicholas J Schork
May 23, 2015·Molecular Cell·Jason A ReuterMichael P Snyder
Aug 19, 2015·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Sarah S ThomasDaniel E Furst
Oct 16, 2015·Nature·Andrew V BiankinSimon J Hollingsworth
Nov 26, 2015·Journal of the National Cancer Institute·Christophe Le TourneauIvan Bièche
Dec 10, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S G SmithJ Cuzick
Dec 19, 2015·The Lancet Oncology·Christophe Le TourneauMaud Kamal
Jan 13, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alaap ShahRobert Miller
Feb 26, 2016·The AAPS Journal·Robert N Schuck, Joseph A Grillo
May 26, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Adriana AlbiniAlberto Costa
Nov 3, 2016·Nature Reviews. Clinical Oncology·Christophe Le Tourneau, Razelle Kurzrock
Mar 3, 2017·Nature Reviews. Clinical Oncology·Giulia SiravegnaAlberto Bardelli
Jun 6, 2017·Nature Biotechnology·Huub SchellekensEnrico Mastrobattista
Jan 15, 2018·Social Science & Medicine·Angus Deaton, Nancy Cartwright
Mar 3, 2018·Experimental & Molecular Medicine·Rolf ApweilerOlaf Wolkenhauer
May 1, 2010·Personalized Medicine·Gary H Lyman, Bradford Hirsch
Aug 31, 2018·Nature Genetics·Andrew J SchorkNicholas J Schork

❮ Previous
Next ❯

Citations

Jan 14, 2021·Clinical Pharmacology and Therapeutics·Karthik VenkatakrishnanSarah A Holstein

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved